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ABSTRACT
Background: Peripheral neuropathy (PN) may be idiopathic, iatrogenic, or be caused by any number of
chronic diseases such as human immunodeficiency virus (HIV) and type 1 diabetes mellitus (DM1). PN is
of particular interest to physical therapists, because it contributes to an individual’s risk of falling. Purpose:
(1) To describe a community-dwelling older adult with HIV, DM1, PN, and neurotoxic medication use (2)
Highlight the pathophysiology of each diagnoses and resulting neuropathy and describe their effect on clinical
decision-making when they are both present. Case Description: A seventy-two year-old man presented to
outpatient physical therapy with PN and concurrent HIV and DM1. Physical examination identified decreased
somatosensation and proprioception amongst other findings. Based on Functional Reach Test (FRT) and
the Activities-Specific Balance Confidence Scale (ABC) fall risk cutoff scores, he was at risk of falling. Due
to his PN, he was hindered in his ability to maintain balance in low-light situations, traverse stairs with
objects in hand, and navigate crowded spaces while traveling and taking photographs. Intervention included
balance-challenging neuromotor exercises, progressing in difficulty, and including static, dynamic, anticipatory,
and reactive balance interventions. Outcomes: Despite chronic health conditions, the patient experienced
meaningful improvements in balance ability and balance confidence. Over 5 sessions of physical therapy in
7 weeks, he improved his scores and was no longer a fall risk on the FRT and ABC. Discussion: PN may
be the result of a single diagnosis, or multiple concurrent diagnoses. Studies are much more likely to include
individuals with PN from a single source, as opposed to multiple concurrent diagnoses. In the presence of
multiple etiologies, it is difficult to determine the best physical therapy intervention approach. Areas for future
research may take two directions: (1) Including patients with coexisting conditions in trials (2) Stratification
with very clear description of diagnoses in studies seeking optimal examination and intervention approaches.
Conclusion: In the absence of clearer guidelines and stratification, an understanding of pathophysiology,
patient goals and expectations, and preliminary published evidence should be used to develop an
individualized approach to evaluating and treating individuals with PN.
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ABSTRACT 
Background: Peripheral neuropathy (PN) may be idiopathic, iatrogenic, or be caused by any number of chronic diseases such as 
human immunodeficiency virus (HIV) and type 1 diabetes mellitus (DM1). PN is of particular interest to physical therapists, because 
it contributes to an individual’s risk of falling.  Purpose: (1) To describe a community-dwelling older adult with HIV, DM1, PN, and 
neurotoxic medication use (2) To highlight the pathophysiology of each diagnoses and resulting neuropathy and describe their 
effect on clinical decision-making when they are both present. Case Description: A seventy-two year-old man presented to 
outpatient physical therapy with PN and concurrent HIV and DM1. Physical examination identified decreased somatosensation 
and proprioception amongst other findings. Based on Functional Reach Test (FRT) and the Activities-Specific Balance Confidence 
Scale (ABC) fall risk cutoff scores, he was at risk of falling.  Due to his PN, he was hindered in his ability to maintain balance in 
low-light situations, traverse stairs with objects in hand, and navigate crowded spaces while traveling and taking photographs. 
Intervention included balance-challenging neuromotor exercises, progressing in difficulty, and including static, dynamic, 
anticipatory, and reactive balance interventions. Outcomes: Despite chronic health conditions, the patient experienced meaningful 
improvements in balance ability and balance confidence.  Over 5 sessions of physical therapy in 7 weeks, he improved his scores 
and was no longer a fall risk on the FRT and ABC. Discussion: PN may be the result of a single diagnosis, or multiple concurrent 
diagnoses. Studies are much more likely to include individuals with PN from a single source, as opposed to multiple concurrent 
diagnoses. In the presence of multiple etiologies, it is difficult to determine the best physical therapy intervention approach. Areas 
for future research may take two directions: (1) Including patients with coexisting conditions in trials (2) Stratification with very clear 
description of diagnoses in studies seeking optimal examination and intervention approaches. Conclusion:  In the absence of 
clearer guidelines and stratification, an understanding of pathophysiology, patient goals and expectations, and preliminary 
published evidence should be used to develop an individualized approach to evaluating and treating individuals with PN. 
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BACKGROUND AND PURPOSE 
The annual medical cost of falls resulting in hospitalization exceeds 3.1 billion dollars in the United States.1 Peripheral neuropathy 
(PN) is a contributing factor for fall risk,2 and neuropathy may impact motor, sensory and/or autonomic peripheral nerves.2 This 
diagnosis is characterized by damage to the nerve and related structures such as myelin surrounding the nerve, and may result in 
pain, muscle weakness, decreased proprioception, decreased somatosensation, reduced or absent ankle reflexes, reduced 
balance control, and higher risk for falling.2,3 PN-induced sensory deficits are typically permanent, but patients can compensate by 
“up-training” other systems.4-7 Many different medical conditions can cause PN. (Table 1)   
 
Table 1: Summary from Streckmann based on review of exercise interventions for PN2 
Source/Type of Peripheral Neuropathy 
Alcohol Induced 
Amyloidosis 
Anti-myelin-associated glycoprotein 
Autoimmune 
Charcot-Marie-Tooth Disease 
Chemotherapy Induced  
Chronic inflammatory demyelinating polyradiculoneuropathy 
Chronic Acquired Peripheral Neuropathy 
Chronic Renal Disease 
Diabetic Peripheral Neuropathy (Type 1 DM) 
Diabetic Peripheral Neuropathy (Type 2 DM) 
Diphtheria 
Hereditary motor and sensory neuropathy (HMSN) 
HIV Induced  
Idiopathic Peripheral Neuropathy 
Infection induced  
Inflammatory peripheral neuropathy after Guillain-Barré Syndrome 
Liver Transplant familial amyloid polyneuropathy (FAP) 
Lyme Disease 
Medication Induced  
Metabolic imbalance induced neuropathy 
Nutritional deficiency induced neuropathy 
Sensory Neuron Disease 
Toxic Neuropathy 
 
Human Immunodeficiency Virus (HIV) and Type 1 Diabetes Mellitus (DM1) are two chronic conditions that both cause peripheral 
neuropathies, but with differing mechanisms.3,8-12 Nationally, 1.1 million people are infected with HIV, and 57% of patients with HIV 
experience a peripheral neuropathy of some type due to medication side-effects and/or immunomodulatory mechanisms.3,8,9 
Similarly, 1 million people are living with DM1, and 33% of these patients develop peripheral neuropathies due to microvascular 
disease.4,10 The pathophysiology of PN varies depending on the disease process or medication side effect. Alterations in DNA, 
protein restructuring, and neuronal dysfunction have all been implicated as potential contributors to PN.13-15 Despite varied 
causations, it is typically difficult to clinically distinguish relative contributions to PN in a patient with multiple risk factors.3,15  
 
Individuals with both HIV and DM1 are prone to have balance deficits from neuropathy and potentially iatrogenic deficits linked to 
medications. Balance training improves balance ability in individuals with DM1-associated peripheral neuropathies.4,16 The 
research for patients with HIV-associated peripheral neuropathies largely focuses on pain control and balance rehabilitation. These 
patients demonstrated decreased center of mass sway during tandem stance and increased gait speed during dual motor-cognitive 
task following balance training.5 
 
PN is well researched in individuals with isolated HIV or DM1, but information is scarce on the implications for PN when these 
conditions exist concurrently, and how training may, or may not be effective in improving balance and function when HIV and DM1 
coexist. Purpose: (1) To describe a community-dwelling older adult with HIV, DM1, PN, and neurotoxic medication use (2) Highlight 
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the pathophysiology of each diagnoses and resulting neuropathy and describe their effect on clinical decision-making when they 
are both present. 
 
CASE DESCRIPTION 
Examination 
A seventy-two year-old man presented to outpatient physical therapy with the primary diagnosis of polyneuropathy associated with 
DM1 and HIV, and concurrent hypertension and hypercholesterolemia. The patient reported a 30-year history of HIV. Onset of 
DM1 was unknown. Given the expected juvenile onset, it was likely that both diseases had been concurrent and interacting for as 
long as 30 years. Physical therapy referral was for decreased balance ability during functional tasks, and he reported difficulty with 
maintaining balance while moving in low-light situations, ascending and descending stairs with objects in hand, and walking in 
crowds. He lived an active life after retiring as a health professional, including frequent travel, recreational photography, and 
participation in community theater. He sustained a non-injurious fall one month earlier while standing on ice and suddenly being 
pulled by his leashed dog. He noted primarily relying on his vision for balance and used eyeglasses for vision correction. He sought 
to improve his confidence in his abilities and reported improved balance after an episode of physical therapy intervention 10 years 
prior. 
 
Table 2.  Medications and clinical symptoms 
Of his thirteen medications (Table 2), 2 were antiretroviral therapies (ARTs), which are associated with PN.3 Although the duration 
of ART use was unknown, it is likely that use of ARTs or other similarly neurotoxic medications spanned most of the 30 years since 
his HIV diagnosis. 
 
Physical Examination 
Based on his history of HIV, DM1, PN, and chronic ART use, it was hypothesized that the patient would present with decreased 
functional balance due to impairments in the musculoskeletal and neuromuscular systems. Following a systems review (see Table 
3), the therapist performed tests and measures of the musculoskeletal and neuromuscular systems including balance, strength, 
sensation, proprioception, and vestibular function (see Table 4). Gait was steady without the use of an assistive device, although 
Medication 
(Generic/Brand) 
Classification/Intended Treatment17 Clinical Significance 
Aspirin Antipyretic, non-opioid analgesic 
Increases risk for gastrointestinal bleeds and 
anemia.17 
Clonazepam/Klonopin® Anticonvulsant, benzodiazepine 
May cause ataxia or hypotonia, contributing to 
balance disturbances.17  
Efavirenz*/Sustiva® Antiretroviral 
Reverse transcriptase inhibitor for HIV-1. An 
ART and therefore associated with PN.3 
Fenofibrate/Lipofen® Lipid-lowering agent May cause nausea, fatigue, and headaches.17  
Fluticasone/Flovent HFA® Steroidal anti-inflammatory 
Can lead to muscle wasting and osteoporosis 
if taken regularly for extended periods of 
time.17  
Furosemide/Lasix® Diuretic 
May cause blurred vision, headaches, and 
dizziness.17 
Hydrochlorothiazide/HCTZ® Antihypertensive, diuretic May cause headache and hyperglycemia.17  
Insulin/Humulin® Antidiabetic, hormone 
May cause hypoglycemia and rarely, diabetic 
ketoacidosis.17 
Lisinopril/Zestril® Antihypertensive, ACE inhibitor 
May occasionally cause hypotension, 
syncope, and dizziness.17 
Omeprazole/Prilosec® Proton-pump inhibitor 
May cause dizziness, headache, nausea, and 
vomiting.17 
Quetiapine/Seroquel® Antipsychotic, mood stabilizer 
May cause agitation, headache, dizziness, 
hypotension, and abdominal pain.17 
Raltegravir*/Isentress® Antiretroviral 
An HIV-1 replication inhibitor. An ART and 
therefore associated with PN.3 
Zolpidem/Ambien® Sedative 
May cause dizziness, headache, and 
drowsiness.17 
*Known to contribute to PN in some patients 
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he occasionally grasped stationary objects as he turned corners.  He did not rely on the objects for major balance correction. 
Because of his reported balance challenges, the Functional Reach Test (FRT) and The Activities-Specific Balance Confidence 
Scale (ABC) were chosen as outcome measures. The scores on both measures indicated risk for falls (See Table 5).18,19 
 
Table 3: Systems review 
System Findings Decision & Rationale 
Cardiovascular/Pulmonary 
Respiration appropriate during rest, 
exercise, and recovery.  No 
cardiovascular data obtained.  
Further examination not indicated for 
pulmonary system. No cardiovascular 
data was obtained. See Discussion. 
Musculoskeletal Difficulty with balance tasks.  
Requires further examination and 
potential intervention. 
Neuromuscular Difficulty with balance tasks. 
Requires further examination and 
potential intervention. 
Integumentary 
Skin appears intact. Patient reports 
performing foot checks based on his 
knowledge as a healthcare professional. 
Further examination not indicated. 
Cognitive/ Communication 
Patient appropriately interacts with 
therapist. 
Further examination not indicated. 
Psycho-emotional 
Mood and responses appear 
appropriate for given situation. 
Further examination not indicated. 
 
 
 
Table 4: Tests and measures 
Impairment Test/Measure Finding 
Static Balance FRT18 6 inches (15.24cm) 
Balance Confidence ABC20 62% 
Proprioception Passive Joint Position Sense21 
Great toe and ankle impaired 
bilaterally 
Sensation Dermatome, Light Touch22 
Diminished in stocking 
pattern bilaterally 
Gross Muscle Strength Myotome Testing23 
No evidence of myotomal 
weakness 
Vestibular Function Vestibulo-Ocular Reflex24 
No evidence of vestibular 
dysfunction 
 
Outcome Measures 
FRT is an assessment of stability in static standing, with strong intrarater and interrater reliability for community-dwelling elderly 
(CDE).18,25 A cut-off score of < 7 inches (17.8 cm) is related to decreased mobility and activities of daily living (ADL).18 The FRT 
was prioritized due to its excellent correlation with walking speed (r = 0.71) and mobility skills (r = 0.65), and its moderate correlation 
with ADL performance (r = 0.48).18 
 
The ABC is a sixteen-question self-report survey that assesses confidence during daily situations that challenge balance. The ABC 
was chosen because the patient had a goal of increasing confidence in his own ability to maintain balance. An ABC score of < 
67% correlates with increased risk of falling in CDE.19 The ABC has excellent correlation with the Berg Balance Scale (BBS) (r = 
0.75) and the Timed Up & Go Test (TUG) (r = 0.69).26 See Table 5 for additional psychometrics of the FRT and ABC. 
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Table 5: Psychometrics of outcome measures 
Measure FRT ABC 
Intrarater Reliability ICC = 0.8918 ICC = 0.9427* 
Interrater Reliability r = 0.9725 r = 0.9228 
Minimal Detectable Change 
(MDC) 
2.88 in. (7.32cm)29* 13%27* 
Standard Error of Mean (SEM) 1.03 in. (2.64cm)29* 1.197%30 
Fall Risk Cut-off < 7 in. (17.8 cm)18 < 67%19 
Internal Consistency – Cronbach’s Alpha = 0.9620 
ICC = Intra-class correlation coefficient 
*Established for patients with Parkinson’s disease 
 
Evaluation 
The patient presented with PN secondary to concurrent HIV, DM1 and neurotoxic medication use, with findings of decreased distal 
lower extremity somatosensation and proprioception bilaterally.  This pathologic process hindered his ability to perform tasks such 
as maintaining balance in low-light situations, traversing stairs with objects in hand, and navigating crowded spaces.  These 
difficulties hindered him in his participations as a traveler and photographer (See Figure 1). 
 
 
Figure 1: ICF model of patient’s condition 
 
Prognosis 
Prognosis considered medical, environmental, and personal factors. Neuropathy and the associated activity limitations are 
expected to gradually worsen as a result of the progressive and chronic nature of his health conditions.3,8-12 Progression of PN was 
expected not only due to the disease processes of DM1 and HIV, but also as a side effect of ART medications.3,12 Additionally, 
CDE who take ≥ 4 medications are at an increased risk for falls.31 He took thirteen medications at the time of evaluation and this 
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number is not expected to decrease as he ages, compounding his fall risk. Therefore, his long-term medical prognosis for 
improvement in balance was poor.  
 
Despite expected PN progression, exercise interventions have been shown to improve motor and sensory function, which translate 
to improved balance and gait.16 Based on existing cutoffs, he was at risk of falls on the FRT and ABC.18,19 In individuals with 
diabetic neuropathy, 8 weeks of balance training focused physical therapy is expected to lead to improvement in FRT and ABC 
scores.32 Balance intervention has also been associated with balance improvement in patients with HIV.5 Accordingly, his short-
term prognosis for improvement in balance function was good.  However, the authors were unable to find information on balance 
improvement in the presence of concurrent diagnoses. 
 
The patient’s prognosis was positively affected by his health literacy and strong social support. Patients with adequate health 
literacy consistently demonstrate better adherence to prescribed interventions and have lesser HIV symptom intensity and body 
change distress.33,34 Adherence also correlates positively with social support.33,35 Overall personal and environmental factors 
therefore indicate that improved functional outcomes were expected.33-35 Considering the negative and positive prognostic factors, 
a long-term progression in PN was expected, but with a short-term improvement in function with physical therapist management. 
 
Plan of Care and Goals 
The plan of care was created from the patient-identified activity and participation limitations in the ICF model. It included 8 weekly 
sessions of static and dynamic balance exercises to train anticipatory and reactive balance, with the goal of enhancing 
compensatory balance strategies. In addition, a 10-minute daily home exercise program (HEP) was planned to reinforce in-clinic 
balance exercises. Goals for the patient (Table 6) were set based on the challenges he identified considering both his personal 
objectives for physical therapy and expectation for clinical improvement. 
 
Table 6: Goals for intervention 
Goal Timeframe Rationale 
Patient will increase FRT 
score by ≥ 2 inches 
 
8 weeks 
Average improvement in FRT score is 8% 
following balance training32 
Patient will increase ABC 
score by ≥ 15% 
 
8 weeks 
Average improvement in ABC score is 
13% following compensatory balance 
training32 
 
Intervention 
Intervention primarily focused on balance-challenging neuromotor exercise (See Table 7). The combination of in-person 
intervention and a HEP met the guidelines for neuromotor exercise prescription per the American College of Sports Medicine.36 
Progression of each exercise occurred as the patient mastered the given exercise, as no optimal strategy for progression of 
neuromotor exercise has been identified.36 The exercises began with a static balance focus including stance on ground, foam, and 
a rocker board, then were progressed to be more dynamic with variations such as challenging balance during walking, plyometric 
stepping, and hopping. Eyes-closed conditions for exercises were included due to his noted visual dominance and in order to “up-
train” vestibular and somatosensory systems. The patient’s personal activity and participation goals were considered as exercise 
was progressed. Due to his scheduling preference, he attended 5 weekly sessions of physical therapy intervention over 7 weeks. 
 
Table 7: Interventions 
Activity Frequency Intensity37 Duration 
Visit Number 
1 2 3 4 5 
Recumbent Biking warm up In Clinic 3 METs 5 min. X X X X X 
Grapevine / Braiding32 Daily (HEP) 3 METs 1 min. X X X X X 
Tandem Walking32 Daily (HEP) 3 METs 1 min. X X X X X 
Standing on Foam32 Daily (HEP) 2 METs 1 min. X X X X X 
Rocker Board4 In Clinic 2 METs 5 min.  X    
Single Limb Stance (Eyes Open)32 In Clinic 3 METs 1 min.   X   
Single Limb Stance (Eyes Closed) 32 In Clinic 3 METs 1 min.   X   
Walking on Uneven Surface (Reactive)32 In Clinic 3 METs 1 min.    X  
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Side-stepping In Clinic 3 METs 1 min.    X  
Grapevine / Braiding In Clinic 3 METs 1 min.    X  
Rocker Board with arms occupied4 In Clinic 2 METs 5 min.    X  
Single-knee on Edge of Bed Balance In Clinic 2 METs 20 sec.    X X 
Balance recovery following supported 
leaning38 
In Clinic 2 METs 1 min.     X 
Quick stepping plyometrics 2” step32 In Clinic 4 METs 1 min.     X 
Walking with quick reactive turns32 In Clinic 4 METs 2 min.     X 
Walking with head turns32 In Clinic 3 METs 2 min.     X 
Two foot hopping32 In Clinic 3 METs 2 min.     X 
MET = Metabolic Equivalent of Task     HEP=Home Exercise Program 
 
OUTCOMES 
Outcome measures were completed upon evaluation and on the final visit. A summary of the outcomes can be found in Table 8 
and in Figure 2. The patient met all stated goals in 7 weeks and he was no longer at risk for falls per the FRT and ABC, although 
he was still 1 inch below age group norms on the FRT.39 Scores below the 7 inch cutoff of FRT identify patients who have difficulty 
leaving the neighborhood on their own, who are limited in mobility skills, and who are most restricted in ADLs.18 Scores on the ABC 
below the 67% cutoff accurately identify people who fall 84% of the time.19  
 
Scores on the ABC and FRT exceeded the published MDC’s for each measure.27,29 The outcomes are meaningful in light of the 
patient’s goals, as they reflect an improvement in performance and confidence with balance related activities. For the patient, this 
meant pursuing traveling and photography without increased fear of falling. 
 
Table 8: Outcomes 
Measure Week 1 Week 7 Fall Risk Cutoff MDC Mean Score 
FRT 6 inches 12 inches < 7 inches18 2.88 inches29* 13.16 inches
39** 
ABC 62% 77% < 67%19 13%27* Unknown 
*For patients with Parkinson’s disease 
**CDE males, 70-87, no recent falls or major neurological or orthopedic diagnoses 
 
 
Figure 2: FRT and ABC outcomes 
 
DISCUSSION 
This case report described the physical therapist management of a community-dwelling older adult with HIV, DM1, PN, and 
neurotoxic medication use, with a focus on pathophysiology and its effect on clinical decision-making. Improvement in balance was 
meaningful to the patient, and the outcome measures related to both patient goals of improving confidence and functional balance 
ability. Confidence in his ability to participate in travel and photography improved over the course of physical therapy treatment. 
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The relative contribution of ART medication, the HIV disease process, and the DM1 disease process on the patient’s neuropathy  
is unknown. Most likely, his PN was the product of multiple pathophysiologic processes that adversely impacted his peripheral 
nerves over time. ART use may lead to mitochondrial DNA damage in axons of peripheral nerves.13 Neurotoxicity may also occur 
secondary to the viral infection of HIV itself – infected macrophages are known to release inflammatory cytokines that may cause 
nerve fiber damage.14 Glycosylated proteins, as a result of DM1, also contribute to nerve dysfunction.15  
 
Current research supports physical therapist management and balance interventions for patients with either HIV, DM1, or PN.4,5,16 
However; the current literature lacks intervention guidance when HIV, DM1, and PN coexist. Notable outcomes in previous studies 
that isolate either HIV or DM1 include decreased postural sway, increased balance confidence, increased gait speed, decreased 
pain (if present), and overall reduced fall risk with balance interventions.4,5,7,16 A review by Streckmann et al indicates that differing 
intervention may be appropriate depending on the source of the neuropathy, “metabolically induced” like with Diabetes Mellitus or 
“non-metabolically induced.”2 Based on their review, they suggested balance intervention for metabolically induced PN focus on 
endurance exercises as a way of reducing body weight, and inducing glycemic control amongst other mechanisms. For PN with a 
non-metabolic etiology, they suggest sensorimotor/balance intervention to induce neural adaptation, taking advantage of the 
nervous system’s plasticity. They specifically suggest that exercises focused on sensorimotor training be limited to 5, and that they 
be performed for twenty to forty seconds to allow recovery, and to minimize “neural fatigue.”2 However, these studies lack guidance 
and information on physical therapist management of an individual with multiple concurrent health conditions. In an individual such 
as the patient in this case, a blend of these two approaches would have been most appropriate.  Shorter duration sensorimotor 
balance interventions with longer breaks may have allowed more complete inter and intra-session recovery.  That said, the reduced 
rest may have been more effective at creating an endurance component, which is recommended in those with DM.2 
 
The patient’s score on the FRT increased by 6 inches in 7 weeks. While this may wholly reflect a balance improvement, alternative 
explanations must be considered. The evaluating therapist gave the patient one trial to complete the FRT each time that it was 
performed. The correct clinical administration of the FRT calls for performing 5 trials and recording the average of the final 3 trials.18 
The performance of only one trial may have led the patient to complete the FRT cautiously and below his true functional level. In 
addition, the follow-up measurement could reflect familiarity with the test and confidence in balance ability following treatment, thus 
providing an inaccurate disparity between the two scores.  Despite this possibility, a 100% increase in score is likely meaningful. 
 
In light of the patient's goals, intervention focused on static and dynamic balance activities. The interventions performed were 
driven by patient input, research findings, and therapist experience, the 3 tenets of Evidence Based Practice; however, more 
targeted and potentially appropriate interventions may have been chosen had a more thorough initial balance evaluation been 
used.40 One suggested measure is the Balance Evaluation Systems Test (BESTest).38 The BESTest provides information on 
specific deficits across the balance systems of biomechanical restraints, stability limits, anticipatory postural adjustments, postural 
responses, sensory orientation, and stability in gait.38 Besides intervention guidance, this measure has excellent correlation with 
the ABC (r = 0.636).38 Intervention could have been structured to specifically address deficits identified by the BESTest.  
 
Several examination items would have provided a more complete picture of the patient prior to intervention.  Achilles’ tendon deep 
tendon reflex (DTR) may have provided information regarding the severity of PN.16 As a standard neurological examination tool, 
DTR testing should be performed with similar patients.16 In future management of similar patients, DTR’s should be included. The 
physical therapist did not obtain blood glucose readings or cardiovascular vital signs from the patient during the episode of care. 
Obtaining these values would have improved patient safety, given the risks of exercising with DM1 and the cardiovascular risk 
profile of hypertension and hypercholesterolemia.16  
 
Despite potentially different etiological processes causing PN, the impairments are thought to be similar across patients.7 However, 
it is currently unclear if the source of PN influences prognosis, progression, and response to physical therapy intervention. This 
case report serves as a foundation for identifying current gaps in the literature in complex individuals with PN. Areas for future 
research may take two directions: (1) Including patients with coexisting conditions in trials (2) Stratification with very clear 
description of diagnoses in studies seeking optimal examination and intervention approaches. 
 
CONCLUSION 
Physical therapists should have an awareness of differing pathophysiological processes in individuals with PN. This case report 
describes an individual with PN due to a combination of concurrent HIV, DM1, and neurotoxic medication use. The relative 
contribution of pathophysiologic and iatrogenic processes was unknown, and results in a complicated clinical presentation. Current 
research lacks guidance for physical therapist management of patients with multiple health conditions that contribute to PN. In the 
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absence of clearer guidelines and stratification, an understanding of pathophysiology, patient goals and expectations, and 
preliminary published evidence should be used to develop an individualized approach to evaluating and treating these individuals. 
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